| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/31/2005 | CN1660779A Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 08/31/2005 | CN1660732A Technique for extracting and preparing policosanol and application |
| 08/31/2005 | CN1660426A Methods for inhibiting brain tumor growth |
| 08/31/2005 | CN1660393A Health products of anti fatigue, decreasing blood pressure and blood fat, against cancer and cancer preyention, and preparing method |
| 08/31/2005 | CN1660387A Health care preparation for regulating functional balance of organs of bowels in human body and preparing method |
| 08/31/2005 | CN1660358A Fleece-flower root drop pills for prolonging life |
| 08/31/2005 | CN1660356A Combination of Tibet medicine of containing salt and possessing medicinal effect health care, and preparation metohd |
| 08/31/2005 | CN1660351A Combination of medication of containing astragalus root and dragon's blood resin and application |
| 08/31/2005 | CN1660343A Combination of medication of containing eucalyptol, limonene and alpha pinene and application |
| 08/31/2005 | CN1660333A Dripping heart pill preparation of 10 drops and preparing method |
| 08/31/2005 | CN1660313A Medication in use for releasing fatigue and preparation method |
| 08/31/2005 | CN1660278A Compound injection of Chinese angelica root and chuanxiong rhizome and preparation method |
| 08/31/2005 | CN1660233A Chinese traditional medicine in use for nursing body and regulating feeling and oneself |
| 08/31/2005 | CN1660186A Preparation of Chinese herbal medicine for fight aganist senium |
| 08/31/2005 | CN1660175A Capsules for nourishing the brain |
| 08/31/2005 | CN1660140A Activity combination of marine life and application |
| 08/31/2005 | CN1660139A Method for preparing oral medication by using extractive from oyster alone |
| 08/31/2005 | CN1660111A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660110A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660109A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660108A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia |
| 08/31/2005 | CN1660074A Crystalline composition containing escitalopram |
| 08/31/2005 | CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders |
| 08/31/2005 | CN1216992C Immunomodulators |
| 08/31/2005 | CN1216909C Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method |
| 08/31/2005 | CN1216900C Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 08/31/2005 | CN1216890C Cyclipostins, method for their production and use of same |
| 08/31/2005 | CN1216884C Dibenz [a.g] quinolizinium derivatives and salts thereof |
| 08/31/2005 | CN1216873C Valsartan salts |
| 08/31/2005 | CN1216872C Quinazoline derivatives and pharmaceutical applications thereof |
| 08/31/2005 | CN1216869C Polymorphic crystalline forms of celecoxib |
| 08/31/2005 | CN1216867C 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors |
| 08/31/2005 | CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/31/2005 | CN1216864C Positive modulators of nicotinic receptor agonists |
| 08/31/2005 | CN1216857C Aniline-derived ligands for thyroid receptor |
| 08/31/2005 | CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
| 08/31/2005 | CN1216638C Genes coding proteins for early liver development and their use indiagnosing and treating liver disease |
| 08/31/2005 | CN1216637C Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 08/31/2005 | CN1216605C Combination therapy for treatment of tumors |
| 08/31/2005 | CN1216599C Polyamine treatment of neurological disorders |
| 08/31/2005 | CN1216598C 药物用途 Drug use |
| 08/30/2005 | US6936718 Reacting with acid mixed with solvent; salt formation |
| 08/30/2005 | US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 08/30/2005 | US6936695 Manufacture and expression of large structural genes |
| 08/30/2005 | US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon |
| 08/30/2005 | US6936689 Peptide antagonists of zonulin and methods for use of the same |
| 08/30/2005 | US6936632 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 08/30/2005 | US6936626 Retinoic acid mimetic anilides |
| 08/30/2005 | US6936621 Use of benzoylalkyl-1,2,3,6-tetrahydropyridines |
| 08/30/2005 | US6936617 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders |
| 08/30/2005 | US6936616 Pyrimidine matrix metalloproteinase inhibitors |
| 08/30/2005 | US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 08/30/2005 | US6936611 Serine protease inhibitors |
| 08/30/2005 | US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 08/30/2005 | US6936602 Benzazepine derivatives, process for the preparation of the same and uses thereof |
| 08/30/2005 | US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 08/30/2005 | US6936597 A conjugate of blocked polymer with a biologically active compound containing reactive hydroxy or amino groups |
| 08/30/2005 | US6936595 Tumour-specific vector for gene therapy |
| 08/30/2005 | US6936594 Gene therapy for cerebrovascular disorders |
| 08/30/2005 | US6936585 Corticotropin releasing factor 2 receptor agonists |
| 08/30/2005 | US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule |
| 08/30/2005 | US6936440 Selecting ligand agonists and antagonists |
| 08/30/2005 | US6936276 For tissue regeneration, applying a multilayer biodegradable matrix of crosslinked proteins and/or polysaccharides, where each layer has porosity to accomodate living cells; bone, joint, cartilage repair |
| 08/30/2005 | US6936250 Polysaccharide encapsualted antigen |
| 08/30/2005 | US6936044 Method and apparatus for the stimulation of hair growth |
| 08/30/2005 | US6935334 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 08/30/2005 | CA2294566C Ikk-.alpha. proteins, nucleic acids and methods |
| 08/30/2005 | CA2164060C Lactate dehydrogenase inhibitors in cosmetic compositions |
| 08/30/2005 | CA2136331C New pharmaceutical uses of krill enzymes |
| 08/30/2005 | CA2133152C Piperidines and piperazines with affinity for 5-ht receptors |
| 08/25/2005 | WO2005077971A1 Novel heparin-binding peptide designed from heparin-binding site of snake poison-origin vascular endothelial growth factor (vegf)-like protein and use tehreof |
| 08/25/2005 | WO2005077970A1 Novel heparin-binding peptide designed from heparin-binding site of snake venom-origin vascular endothelial growth factor (vegf)-like protein and use thereof |
| 08/25/2005 | WO2005077905A1 Fused-ring 4-oxopyrimidine derivative |
| 08/25/2005 | WO2005077900A1 Bicyclic amide derivatives |
| 08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
| 08/25/2005 | WO2005077384A1 Lipase activity inhibitor containing high-molecular weight polyphenol fraction, tea extract and process for producing the same |
| 08/25/2005 | WO2005077359A1 Stabilized pharmaceutical composition containing indoline compound |
| 08/25/2005 | WO2005077349A1 HUMAN β-DEFENSIN PRODUCTION ACCELERATOR |
| 08/25/2005 | US20050187294 With lipoxin analog inhibitors of polyisoprenyl phosphate signaling; treating diseases associated with phospholipase D (PLD) initiated polymorphoneutrophil (PMN) inflammation |
| 08/25/2005 | US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction |
| 08/25/2005 | US20050187284 Integrin receptor inhibitors |
| 08/25/2005 | US20050187282 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 08/25/2005 | US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 08/25/2005 | US20050187271 and for reducing undesirable side effects of antitumor agents |
| 08/25/2005 | US20050187269 Benzimidazole derivative and use thereof |
| 08/25/2005 | US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints |
| 08/25/2005 | US20050187257 Methods of treating sepsis |
| 08/25/2005 | US20050187255 Novel curcumin analogues and uses thereof |
| 08/25/2005 | US20050187248 Making 4-((Z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; desalting an oxime intermediate, reacting with 2,4-dimethyl-3-(4-oxopiperidin-1-ylcarbonyl)pyridine-n-oxide, cyanation, organometallic; scale-up; chemokine receptor 5 (CCR5) |
| 08/25/2005 | US20050187246 Cell proliferation inhibitors |
| 08/25/2005 | US20050187236 Nitrogen-containing aromatic derivatives |
| 08/25/2005 | US20050187235 Pyrimidine derivatives useful as selective COX-2 inhibitors |
| 08/25/2005 | US20050187229 Crystalline forms of valacyclovir hydrochloride |
| 08/25/2005 | US20050187228 Derivatives of purine, their preparation process and pharmaceutical compositions containing them |
| 08/25/2005 | US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis |
| 08/25/2005 | US20050187197 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof |
| 08/25/2005 | US20050187194 fructose 1,6-bisphosphatase (FBPase) inhibitors for diabetic complications, hyperlipidemia, hypertension, arteriosclerosis, macroangiopathy; 2-amino-5-isobutyl-4-{2-[5-(N,N'-bis((S)-1-ethoxycarbonyl)ethyl)phosphonamido]furanyl}thiazole |
| 08/25/2005 | US20050187179 treatment of tumors which have increased Notch expression; administration of either Notch antisense oligonucleotides or monoclonal antibodies directed to Notch along with cell differentiating agent |
| 08/25/2005 | US20050187145 template-fixed beta -hairpin peptidomimetics incorporating a template-fixed chain of 7 or 11 alpha -amino acid residues which, depending on their position in the chain, are Gly, or Pro, or of certain types; inhibitors of various serine proteases such as trypsin, human cathepsin G, and thrombin |